(Q48725317)

15 February 2018

title

Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. (English)

1 reference

15 February 2018

author

Jens Juul Holst

series ordinal

2

1 reference

15 February 2018

author name string

L Simonsen

series ordinal

1

1 reference

15 February 2018

C F Deacon

series ordinal

3

1 reference

15 February 2018

publication date

31 January 2006

1 reference

15 February 2018

published in

Diabetologia

1 reference

15 February 2018

volume

49

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

706-712

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-005-0128-9

exact match

0 references

cites work

Proteins of the kidney microvillus membrane. Identification of subunits after sodium dodecylsullphate/polyacrylamide-gel electrophoresis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-005-0128-9

Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4

21 January 2018

1 reference

12 December 2020

A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro

1 reference

12 December 2020

Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs

1 reference

12 December 2020

Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells

1 reference

12 December 2020

Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides

1 reference

12 December 2020

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man

1 reference

12 December 2020

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

1 reference

12 December 2020

1 reference

12 December 2020

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas

1 reference

12 December 2020

Renal tubular processing of small peptide hormones

1 reference

12 December 2020

In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.

1 reference

12 December 2020

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

12 December 2020

Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states

1 reference

12 December 2020

Renal catabolism of truncated glucagon-like peptide 1

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

12 December 2020

Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig

1 reference

12 December 2020

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

12 December 2020

Glucagon metabolism in the rat

1 reference

12 December 2020

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

12 December 2020

Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology

1 reference

12 December 2020

In Vivoandin VitroDegradation of Glucagon-Like Peptide-2 in Humans1

1 reference

12 December 2020

Renal effects of glucagon-like peptide in rats

1 reference

12 December 2020

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

1 reference

12 December 2020

Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.

1 reference

12 December 2020

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

12 December 2020

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

1 reference

12 December 2020

Transport and hydrolysis of glucagon in the proximal nephron

1 reference

12 December 2020

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

12 December 2020

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

1 reference

12 December 2020

10.1007/S00125-005-0128-9

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

16447056

1 reference

15 February 2018